Sepsis: a Review for the Neurohospitalist

Overview

Journal Neurohospitalist

Publisher Sage Publications

Date 2013 Aug 29

PMID 23983879

Citations 6

Authors

Lioudmila V Karnatovskaia

Emir Festic

Affiliations

Soon will be listed here.

Abstract

Sepsis represents a major challenge in medicine. It begins as a systemic response to infection that can affect virtually any organ system, including the central and peripheral nervous systems. Akin to management of stroke, early recognition and treatment of sepsis are just as crucial to a successful outcome. Sepsis can precipitate myasthenic crisis and lead to encephalopathy and critical illness neuropathy. Stroke and traumatic brain injury can predispose a patient to develop sepsis, whereas Guillain-Barré syndrome is similarly not uncommon following infection. This review article will first describe the essential principles of sepsis recognition, pathophysiology, and management and will then briefly cover the neurologic aspects associated with sepsis. Vigilant awareness of the clinical features of sepsis and timeliness of intervention can help clinicians prevent progression of this disease to a multisystem organ failure, which can be difficult to reverse even after the original source of infection is under control.

Citing Articles

Rapid detection of in blood culture samples using human IgG-based lateral flow assay.

Srisrattakarn A, Charoensri N, Prompipak J, Ouancharee W, Saiboonjan B, Tippayawat P Microbiol Spectr. 2024; 12(2):e0304623.

PMID: 38230955 PMC: 10846088. DOI: 10.1128/spectrum.03046-23.

Activated mesenchymal stem cells increase drug susceptibility of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Esfandiary R, Saeedi P, Saffarian P, Halabian R, Fooladi A Folia Microbiol (Praha). 2023; 69(1):145-154.

PMID: 37924430 DOI: 10.1007/s12223-023-01099-z.

Dysregulation of human beta-defensin-3 expression in the peripheral blood of patients with sepsis.

Al Mansour N, Al-Kafaji G, Mahmeed A, Bindayna K SAGE Open Med. 2021; 9:20503121211041515.

PMID: 34457302 PMC: 8385589. DOI: 10.1177/20503121211041515.

The Long Pentraxin PTX3 Controls Severe Infection.

Asgari F, Supino D, Parente R, Polentarutti N, Stravalaci M, Porte R Front Immunol. 2021; 12:666198.

PMID: 34093560 PMC: 8173212. DOI: 10.3389/fimmu.2021.666198.

Cannabinoid CB Receptor Antagonist Rimonabant Decreases Levels of Markers of Organ Dysfunction and Alters Vascular Reactivity in Aortic Vessels in Late Sepsis in Rats.

Leite-Avalca M, Staats F, Verona D, de Souza P, Almeida M, Silva-Santos J Inflammation. 2018; 42(2):618-627.

PMID: 30556096 DOI: 10.1007/s10753-018-0919-z.

References

Angus D, Lidicker J, Clermont G, Carcillo J, Pinsky M . Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29(7):1303-10. DOI: 10.1097/00003246-200107000-00002. View

Seguin P, Fedun Y, Laviolle B, Nesseler N, Donnio P, Malledant Y . Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care. J Antimicrob Chemother. 2009; 65(2):342-6. DOI: 10.1093/jac/dkp439. View

Bolton C . Neuromuscular manifestations of critical illness. Muscle Nerve. 2005; 32(2):140-63. DOI: 10.1002/mus.20304. View

Heumann D, Glauser M, Calandra T . Molecular basis of host-pathogen interaction in septic shock. Curr Opin Microbiol. 1999; 1(1):49-55. DOI: 10.1016/s1369-5274(98)80142-2. View

Iacobone E, Bailly-Salin J, Polito A, Friedman D, Stevens R, Sharshar T . Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med. 2010; 37(10 Suppl):S331-6. DOI: 10.1097/CCM.0b013e3181b6ed58. View

Paulus P, Jennewein C, Zacharowski K . Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?. Biomarkers. 2011; 16 Suppl 1:S11-21. DOI: 10.3109/1354750X.2011.587893. View

Bone R . Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med. 1996; 125(8):680-7. DOI: 10.7326/0003-4819-125-8-199610150-00009. View

Iwashyna T, Wesley Ely E, Smith D, Langa K . Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010; 304(16):1787-94. PMC: 3345288. DOI: 10.1001/jama.2010.1553. View

Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B . Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2002; 345(19):1368-77. DOI: 10.1056/NEJMoa010307. View

10.

Hall M, Williams S, DeFrances C, Golosinskiy A . Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS Data Brief. 2011; (62):1-8. View

11.

Ertmer C, Bone H, Morelli A, Van Aken H, Erren M, Lange M . Methylprednisolone reverses vasopressin hyporesponsiveness in ovine endotoxemia. Shock. 2007; 27(3):281-8. DOI: 10.1097/01.shk.0000235140.97903.90. View

12.

Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R . A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004; 350(22):2247-56. DOI: 10.1056/NEJMoa040232. View

13.

Brower R, Matthay M, Morris A, Schoenfeld D, Thompson B, Wheeler A . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1301-8. DOI: 10.1056/NEJM200005043421801. View

14.

Jones A, Shapiro N, Trzeciak S, Arnold R, Claremont H, Kline J . Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010; 303(8):739-46. PMC: 2918907. DOI: 10.1001/jama.2010.158. View

15.

Sprung C, Annane D, Keh D, Moreno R, Singer M, Freivogel K . Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008; 358(2):111-24. DOI: 10.1056/NEJMoa071366. View

16.

Meisel C, Schwab J, Prass K, Meisel A, Dirnagl U . Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005; 6(10):775-86. DOI: 10.1038/nrn1765. View

17.

Funk D, Kumar A . Antimicrobial therapy for life-threatening infections: speed is life. Crit Care Clin. 2010; 27(1):53-76. DOI: 10.1016/j.ccc.2010.09.008. View

18.

Brunkhorst F, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N . Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008; 358(2):125-39. DOI: 10.1056/NEJMoa070716. View

19.

Beale R, Janes J, Brunkhorst F, Dobb G, Levy M, Martin G . Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry. Crit Care. 2010; 14(3):R102. PMC: 2911744. DOI: 10.1186/cc9044. View

20.

Hough C, Steinberg K, Thompson B, Rubenfeld G, Hudson L . Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med. 2008; 35(1):63-8. PMC: 2861487. DOI: 10.1007/s00134-008-1304-4. View